What is Liraglutide?
Category: Prescription Drugs
Most popular types: Victoza Saxenda
Liraglutide is an injectable medicine used for type 2 diabetes that helps control blood sugar levels. It works by increasing the amount of insulin that the body produces, decreasing the amount of sugar produced by the liver, and slowing the time it takes food to go through the stomach.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 1399 | 73 | |
| Support weight loss | 44 | 23 | |
| Obesity | 10 | 11 | |
| Elevated blood sugar (hyperglycemia) | 3 | 0 | |
| Insulin resistance | 3 | 0 | |
| Prediabetes | 3 | 2 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 15 | |
| Moderate | 13 | |
| Mild | 15 | |
| None | 38 |
Commonly reported side effects and conditions associated with Liraglutide
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 17 | |
| Decreased appetite | 4 | |
| Headaches | 4 | |
| Diarrhea | 3 | |
| Fatigue | 3 | |
| Abdominal bloating | 2 |
Why patients stopped taking Liraglutide
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 18 | |
| Doctor's advice | 10 | |
| Did not seem to work | 8 | |
| Other | 6 | |
| Change in health plan coverage | 5 | |
| Expense | 4 | |
| Course of treatment ended | 3 | |
| Personal research | 2 |
Duration
Stopped taking Liraglutide
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 10 | |
| 1 - 6 months | 6 | |
| 6 months - 1 year | 10 | |
| 1 - 2 years | 7 | |
| 2 - 5 years | 6 | |
| 5 - 10 years | 3 |
What people switch to and from
Patients started taking Liraglutide after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Metformin (Metformin ER) | 18 | |
| Exenatide (Bydureon) | 4 | |
| Glimepiride (Amaryl) | 4 | |
| Glyburide (Euglukon) | 3 | |
| Sitagliptin (Januvia) | 2 |
Patients stopped taking Liraglutide and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Exenatide (Bydureon) | 4 | |
| Dapagliflozin (Farxiga) | 3 | |
| Dulaglutide (Trulicity) | 3 | |
| Semaglutide (Ozempic) | 3 | |
| insulin detemir (Levemir) | 2 |
Last updated: